These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32616342)

  • 1. Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study.
    Gitto S; De Maria N; Marzi L; Magistri P; Falcini M; Vitale G; Olivieri T; Guerrini GP; Serra V; Forte P; Carrai P; De Simone P; Mega A; Zoller H; Piai G; Schepis F; Marocchi M; Villa E; Marra F; Andreone P; Di Benedetto F;
    Eur J Intern Med; 2020 Sep; 79():70-75. PubMed ID: 32616342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study.
    Gitto S; Magistri P; Marzi L; Mannelli N; De Maria N; Mega A; Vitale G; Valente G; Vizzutti F; Villa E; Marra F; Andreone P; Falcini M; Catellani B; Guerrini GP; Serra V; Di Sandro S; Ballarin R; Piai G; Schepis F; Margotti M; Cursaro C; De Simone P; Petruccelli S; Carrai P; Forte P; Campani C; Zoller H; Di Benedetto F;
    Ann Hepatol; 2022; 27(3):100683. PubMed ID: 35151902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors.
    De Luca L; Kalafateli M; Bianchi S; Alasaker N; Buzzetti E; Rodríguez-Perálvarez M; Thorburn D; O'Beirne J; Patch D; Leandro G; Westbrook R; Tsochatzis EA
    Liver Int; 2019 Aug; 39(8):1557-1565. PubMed ID: 31233663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Pretransplant Diabetes on Outcomes After Liver Transplantation: An Updated Meta-analysis With Systematic Review.
    Tang ASP; Tan C; Lim WH; Ng CH; Tan DJH; Zeng R; Xiao J; Ong EYH; Cho E; Chung C; Lim WS; Chee D; Nah B; Tseng M; Syn N; Bonney G; Liu K; Huang DQ; Muthiah M; Siddiqui MS; Tan EXX
    Transplantation; 2024 May; 108(5):1157-1165. PubMed ID: 37899382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Modifiable Predictors of Long-Term Survival in Liver Transplant Recipients With Diabetes Mellitus Using Machine Learning.
    Yasodhara A; Dong V; Azhie A; Goldenberg A; Bhat M
    Liver Transpl; 2021 Apr; 27(4):536-547. PubMed ID: 33113221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.
    Aravinthan AD; Fateen W; Doyle AC; Venkatachalapathy SV; Issachar A; Galvin Z; Sapisochin G; Cattral MS; Ghanekar A; McGilvray ID; Selzner M; Grant DR; Selzner N; Lilly LB; Renner EL; Bhat M
    Transplantation; 2019 Dec; 103(12):2523-2530. PubMed ID: 30985734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
    World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Predictors, and Impact on Survival of Long-term Cardiovascular Events After Liver Transplantation.
    Sastre L; García R; Gándara JG; Ruiz P; Lombardo J; Colmenero J; Navasa M; Crespo G
    Transplantation; 2020 Feb; 104(2):317-325. PubMed ID: 31335770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes With or Without Hypertension Does Not Affect Graft Survival and All-cause Mortality After Liver Transplant: A Propensity Score Matching Analysis.
    Kwon HM; Moon YJ; Jung KW; Sang BH; Hwang GS
    Transplant Proc; 2018 May; 50(4):1123-1128. PubMed ID: 29731078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Virological Response Is Associated with a Decreased Risk of Posttransplant Diabetes Mellitus in Liver Transplant Recipients with Hepatitis C-Related Liver Disease.
    Roccaro GA; Mitrani R; Hwang WT; Forde KA; Reddy KR
    Liver Transpl; 2018 Dec; 24(12):1665-1672. PubMed ID: 30291672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
    D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
    Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
    Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
    Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.
    Watt KD; Pedersen RA; Kremers WK; Heimbach JK; Charlton MR
    Am J Transplant; 2010 Jun; 10(6):1420-7. PubMed ID: 20486907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients.
    Di Cola S; Cusi G; Lapenna L; Gazda J; Fonte S; Mattana M; Mennini G; Pasqualetti P; Merli M
    Can J Gastroenterol Hepatol; 2023; 2023():2199193. PubMed ID: 37396501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcome?
    Herreras López J; Puchades L; Di Maira T; Cañada AJ; Maupoey J; López-Andújar R; Prieto Castillo M; Berenguer Haym M; Aguilera V
    Rev Esp Enferm Dig; 2022 Oct; 114(10):586-591. PubMed ID: 35045717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
    Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
    Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical implications of pre-liver transplant diabetes on post-liver transplant outcomes in patients with NASH: analysis of the UNOS database.
    Lee DU; Han J; Lee KJ; Kwon J; Fan GH; Jung D; Urrunaga NH
    Hepatol Int; 2022 Dec; 16(6):1448-1457. PubMed ID: 36088499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients.
    Di Maira T; Rubin A; Puchades L; Aguilera V; Vinaixa C; Garcia M; De Maria N; Villa E; Lopez-Andujar R; San Juan F; Montalva E; Perez J; Prieto M; Berenguer M
    Liver Transpl; 2015 Jun; 21(6):812-22. PubMed ID: 27396823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.